Literature DB >> 30148659

Clinical Significance of 4L Lymph Node Dissection in Left Lung Cancer.

Ya-Nan Wang1, Shuang Yao1, Chang-Li Wang1, Mei-Shuang Li1, Lei-Na Sun1, Qing-Na Yan1, Shao-Wen Tang1, Zhen-Fa Zhang1.   

Abstract

PURPOSE: To investigate the prognostic impact of 4L lymph node (LN) dissection in left lung cancer and to analyze the relative risk factors for 4L LN metastasis. PATIENTS AND METHODS: We retrospectively collected data from 657 patients with primary left lung cancer who underwent surgical pulmonary resection from January 2005 to December 2009. One hundred thirty-nine patients underwent 4L LN dissection (4LD+ group); the other 518 patients did not receive 4L LN dissection (4LD- group). Propensity score weighting was applied to reduce the effects of observed confounding between the two groups. Study end points were disease-free survival (DFS) and overall survival (OS).
RESULTS: The metastasis rate of station 4L was 20.9%, which was significantly higher than those of station 7 (14.0%; P = .048) and station 9 (9.8%; P < .001). Station 4L metastasis was associated with most other LN station metastases in univariate analysis, but only station 10 LN metastasis was an independent risk factor for 4L LN metastasis (odds ratio, 0.253; 95% CI, 0.109 to 0.588; P = .001) in multivariate logistic analysis. The 4LD+ group had a significantly better survival than the 4LD- group (5-year DFS, 54.8% v 42.7%; P = .0376; 5-year OS, 58.9% v 47.2%; P = .0200). After allowing potential confounders in multivariate survival analysis, dissection of 4L LN retained its independent favorable effect on DFS (hazard ratio, 1.502; 95% CI, 1.159 to 1.947; P = .002) and OS (hazard ratio, 1.585; 95% CI, 1.222 to 2.057; P = .001). Propensity score weighting further confirmed that the 4LD+ group had a more favorable DFS ( P = .0014) and OS ( P < .001) than the 4LD- group.
CONCLUSION: Station 4L LN involvement is not rare in left lung cancer, and dissection of the 4L LN station seems to be associated with a more favorable prognosis as compared with those who did not undergo this dissection.

Entities:  

Mesh:

Year:  2018        PMID: 30148659     DOI: 10.1200/JCO.2018.78.7101

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  8 in total

1.  Prognostic significance of 4R lymph node dissection in patients with right primary non-small cell lung cancer.

Authors:  Di Zhou; Dongsheng Yue; Zhenfa Zhang; Pengfei Tian; Yingnan Feng; Zuo Liu; Bin Zhang; Meng Wang; Xiaoliang Zhao; Changli Wang
Journal:  World J Surg Oncol       Date:  2022-07-01       Impact factor: 3.253

2.  Anlotinib suppresses lymphangiogenesis and lymphatic metastasis in lung adenocarcinoma through a process potentially involving VEGFR-3 signaling.

Authors:  Tingting Qin; Zhujun Liu; Jing Wang; Junling Xia; Shaochuan Liu; Yanan Jia; Hailin Liu; Kai Li
Journal:  Cancer Biol Med       Date:  2020-08-15       Impact factor: 4.248

3.  Clinical significance and outcomes of bilateral and unilateral recurrent laryngeal nerve lymph node dissection in esophageal squamous cell carcinoma: A large-scale retrospective cohort study.

Authors:  Shuishen Zhang; Qianwen Liu; Bin Li; Minghan Jia; Xiaoli Cai; Weixiong Yang; Shufen Liao; Zhongkai Wu; Chao Cheng; Jianhua Fu
Journal:  Cancer Med       Date:  2022-02-17       Impact factor: 4.452

4.  Study on the Correlation Between CT Features and Vascular Tumor Thrombus Together With Nerve Invasion in Surgically Resected Lung Adenocarcinoma.

Authors:  Yu Song; Daiwen Chen; Duohuang Lian; Shangwen Xu; Hui Xiao
Journal:  Front Surg       Date:  2022-06-28

5.  Development and validation of a nomogram model for the prediction of 4L lymph node metastasis in thoracic esophageal squamous cell carcinoma.

Authors:  Lei Xu; Jia Guo; Shu Qi; Hou-Nai Xie; Xiu-Feng Wei; Yong-Kui Yu; Ping Cao; Rui-Xiang Zhang; Xian-Kai Chen; Yin Li
Journal:  Front Oncol       Date:  2022-10-03       Impact factor: 5.738

6.  Mediastinal lymph node evaluation, especially at station 4L, in left upper lobe lung cancer.

Authors:  Jun Hanaoka; Makoto Yoden; Keigo Okamoto; Ryosuke Kaku; Yasuhiko Ohshio
Journal:  J Thorac Dis       Date:  2022-09       Impact factor: 3.005

7.  Lymph node dissection in the left upper lobe: clinical outcomes and surgical techniques in Japan.

Authors:  Hiroaki Kuroda; Yusuke Sugita; Keita Nakanishi; Yukinori Sakao
Journal:  Mediastinum       Date:  2019-05-07

8.  Significance of risk factor analysis and dissection for station 4L lymphatic metastasis in left lung cancer: a systematic review and meta-analysis.

Authors:  Chu-Xu Wang; Chun Xu; Chang Li; Cheng Ding; Jun Chen; Jun Zhao
Journal:  Transl Cancer Res       Date:  2021-04       Impact factor: 1.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.